Clinical Research Organization (CRO) is a service organization that provides support to the pharmaceutical and biotechnology industries in the form of outsourced pharmaceutical research services. Full-Service Clinical Research Organization offer a full range of services covering drug development from start to finish. Full-Service Clinical Research Organization offer all the services of regulatory affairs, site selection and activation, site management, monitoring, data management, logistics management, pharmacovigilance, biostatistics, medical writing, and project management.
Market Analysis and Insights: Global and United States Full-Service Clinical Research Organization (CRO) Market
This report focuses on global and United States Full-Service Clinical Research Organization (CRO) market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Full-Service Clinical Research Organization (CRO) market size is estimated to be worth US$ 18350 million in 2022 and is forecast to a readjusted size of US$ 33230 million by 2028 with a CAGR of 10.4% during the review period. Fully considering the economic change by this health crisis, by Type, Clinical CRO accounting for % of the Full-Service Clinical Research Organization (CRO) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by End Use, Small Medium Enterprise was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
Global Full-Service Clinical Research Organization (CRO) key players include IQVIA, Labcorp, Syneos Health, PPD, ICON, etc. Global top three players hold a share about 30%. North America is the largest market, with a share about 45%, followed by APAC and Europe, both have a share about 50 percent.
Global Full-Service Clinical Research Organization (CRO) Scope and Market Size
Full-Service Clinical Research Organization (CRO) market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Full-Service Clinical Research Organization (CRO) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Full-Service Clinical Research Organization (CRO) market size by players, by Type and by End Use, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Clinical CRO
Preclinical CRO
Segment by End Use
Small Medium Enterprise
Large Enterprise
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
IQVIA
Labcorp
Syneos Health
PPD
ICON
PRA
Parexel
Medpace
Wuxi Apptec
EPS International
Worldwide Clinical Trials
CMIC
Premier Research
Courante Oncology
PROMETRIKA